Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY

v3.21.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2019   159,711      
Beginning balance at Dec. 31, 2019 $ 1,314,592 $ 1,597 $ 4,207,554 $ (46,833) $ (2,847,726)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (517,538)       (517,538)
Other Comprehensive Income (15,030)     (15,030)  
Stock Compensation 2,104   2,104    
Shares Repurchased (in shares)   (80)      
Shares Repurchased (79) $ (1) (78)    
Issuance of Restricted Stock (in shares)   211      
Issuance of Restricted Stock 0 $ 2 (2)    
Ending balance (in shares) at Mar. 31, 2020   159,842      
Ending balance at Mar. 31, 2020 $ 784,049 $ 1,598 4,209,578 (61,863) (3,365,264)
Beginning balance (in shares) at Dec. 31, 2020 160,800 160,762      
Beginning balance at Dec. 31, 2020 $ (300,500) $ 1,607 4,213,752 (43,000) (4,472,859)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income 8,780        
Other Comprehensive Income 2,570     2,570  
Stock Compensation 1,419   1,419    
Shares Repurchased (in shares)   (86)      
Shares Repurchased (8) $ (1) (7)    
Issuance of Restricted Stock (in shares)   203      
Issuance of Restricted Stock $ 1 $ 3 (2)    
Ending balance (in shares) at Mar. 31, 2021 160,900 160,878      
Ending balance at Mar. 31, 2021 $ (287,738) $ 1,609 $ 4,215,162 $ (40,430) $ (4,464,079)